Nippon Chemiphar Co., Ltd. (4539) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Nippon Chemiphar Co., Ltd. (4539:JPX), powered by AI.

Current Price
¥1,533
P/E Ratio
18.8
Market Cap
5.5B
Sector
Healthcare
What is the Nippon Chemiphar Co., Ltd. stock price forecast?

Nippon Chemiphar Co., Ltd. is currently trading at ¥1,533. View real-time AI analysis on Alpha Lenz.

What is Nippon Chemiphar Co., Ltd. insider trading activity?

View the latest insider trading data for Nippon Chemiphar Co., Ltd. on Alpha Lenz.

What is Nippon Chemiphar Co., Ltd.'s P/E ratio?

Nippon Chemiphar Co., Ltd.'s P/E ratio is 18.8.

Nippon Chemiphar Co., Ltd.

JPX · 4539
¥1,533+5(+0.33%)Market closedJPX regular session 09:00–15:00 JST
Ask about Nippon Chemiphar Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Nippon Chemiphar Co., Ltd. trades at a P/E of 18.8 (fair value) with modest ROE of 1.6%.

Ask for details

Company Overview

Nippon Chemiphar Co., Ltd. is a pharmaceutical company focused on the development, manufacturing, and marketing of medical and pharmaceutical products. Its primary function is to provide innovative solutions in the healthcare industry, with a particular emphasis on generic drugs and research-driven proprietary medicines. The company plays a significant role in the healthcare sector by ensuring the availability of cost-effective medication and contributing to medical advancements through research and development. Nippon Chemiphar operates in various therapeutic areas, including cardiovascular, metabolic, and infectious diseases, enhancing patient outcomes with high-quality pharmaceuticals. Founded in Japan, the company adheres to stringent regulatory standards, ensuring safety and efficacy in all its offerings. Its market significance is underscored by its commitment to addressing medical needs and fostering alliances with global research institutions, thereby enhancing its competitive edge in the pharmaceutical landscape.

CEOMr. Kazushiro Yamaguchi
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees855

Company Statistics

FY 2025

Profile

¥5,531,254,092Market Cap
¥32,570,000,000Revenue
0.00Shares Out
855Employees

Margins

26.85%Gross
6.19%EBITDA
1.86%Operating
0.78%Pre-Tax
0.90%Net

Valuation

18.81P/E
0.29P/B
0.17EV/Sales
8.22EV/EBITDA
-2.61P/FCF

Growth (CAGR)

0.07%Rev 3Yr
0.51%Rev 5Yr
-9.72%Op Inc 3Yr
10.71%Op Inc 5Yr
-25.11%Net Inc 3Yr
-7.58%Net Inc 5Yr

Returns

0.59%ROA
1.56%ROE
0.91%ROIC

Financial Health

¥7,021,000,000Cash & Cash Equivalents
¥23,663,000,000Net Debt
160.09%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Nippon Chemiphar Co., Ltd. (ticker: 4539) is a company listed on JPX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 855 employees. Market cap is $5.5B.

The current price is 1,533 with a P/E ratio of 18.81x and P/B of 0.29x.

ROE is 1.56% and operating margin is 1.86%. Annual revenue is $32.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Nippon Chemiphar Co., Ltd. (4539) Stock Forecast 2026 ¥1,533 — Price, Financials & Analyst Targets | Alpha Lenz